← SynDRA
CUDC-101
SynDRA canonical compound SYN0020706 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | EGFR | ERBB2 |
|---|
| Mechanism of action | EGFR inhibitor |
|---|
All known targets
- EGFR
- ERBB2
- HDAC1
- HDAC10
- HDAC2
- HDAC3
- HDAC4
- HDAC5
- HDAC6
- HDAC7
- HDAC8
- HDAC9
Mechanisms of action (all sources)
- EGFR INHIBITOR
- Epidermal growth factor receptor erbB1 inhibitor
- ERBB2 INHIBITOR
- Receptor protein-tyrosine kinase erbB-2 inhibitor
- HDAC1 INHIBITOR
- Histone deacetylase inhibitor
- HDAC3 INHIBITOR
- HDAC6 INHIBITOR
- HDAC2 INHIBITOR
- HDAC5 INHIBITOR
- HDAC7 INHIBITOR
- HDAC8 INHIBITOR
Cross-references
Synonyms
- CUDC 101
- CUDC101
- 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide
- UNII-1A7Y9MP123
- CHEMBL598797
- 1A7Y9MP123
- 7-[[4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yl]oxy]-N-hydroxyheptanamide
- AK174946
- 7-((4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide
- 7-({4-[(3-ethynylphenyl)amino]-7-methoxyquinazolin-6-yl}oxy)-N-hydroxyheptanamide
- 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide
- PubChem19149
- RefChem:128734
- DTXCID7066275
- HDAC/EGFR/HER2 Inhibitor CUDC-101
- MFCD15528940
- CUDC-101, Free Base
- EPZ005687 hydrochloride
- EPZ015938 hydrochloride
- SCHEMBL93769
- MLS006010163
- GTPL8894
- orb1304532
- CUDC 101 [WHO-DD]
- SCHEMBL29350202
- SCHEMBL29379912
- CUDC-101?
- EX-A842
- GLXC-05386
- HMS3654C20
- BDBM50307768
- NSC800081
- s1194
- AKOS022526176
- CCG-264856
- compound 8 [PMID: 20143778]
- FC20592
- NSC-800081
- SB19287
Look up CUDC-101 in the interactive SynDRA portal →